Detalhe da pesquisa
1.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol
; 41(4): 655-662, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246287
2.
Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature.
J Oncol Pharm Pract
; 27(3): 766-770, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32838682
3.
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Hematol Oncol
; 38(4): 439-445, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495944
4.
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Ann Hematol
; 99(2): 277-282, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872362
5.
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
J Cell Physiol
; 234(7): 11188-11199, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30565691
6.
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
Hematol Oncol
; 35(4): 561-566, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27791277
7.
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.
Acta Haematol
; 137(1): 7-14, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27820922
8.
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 172(6): 879-88, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26763986
9.
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Ann Hematol
; 100(1): 303-304, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219839
10.
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Br J Haematol
; 169(4): 544-51, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25817296
11.
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.
Blood
; 122(23): 3759-66, 2013 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24085766
12.
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines.
Hematol Oncol
; 33(4): 166-75, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25394177
13.
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era.
Haematologica
; 99(1): 125-30, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23935023
14.
The undergraduate nursing student evaluation of clinical learning environment: an Italian survey.
Prof Inferm
; 67(1): 55-61, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24762774
15.
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
Br J Haematol
; 163(1): 40-6, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23889344
16.
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients.
Br J Haematol
; 180(4): 600-602, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27785782
17.
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.
Eur J Haematol
; 90(4): 345-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23336938
18.
Combination of low doses of enzastaurin and lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines.
Ann Hematol
; 91(10): 1613-22, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22623160
19.
Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.
Cancers (Basel)
; 14(3)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158787
20.
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Cancers (Basel)
; 14(23)2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497442